FSD Pharma Generates $7.7 Million in Proceeds and 670% Return on Investment through Sale of Interest in Cannara Biotech
TORONTO--(BUSINESS WIRE)--Feb 20, 2020-- |!| Fort Madison
TORONTO--(BUSINESS WIRE)--Feb 20, 2020-- |!| Fort Madison